Your browser doesn't support javascript.
loading
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery.
Li, Jielin; Pohl, Laura; Schüler, Julia; Korzeniewski, Nina; Reimold, Philipp; Kaczorowski, Adam; Hou, Weibin; Zschäbitz, Stefanie; Nientiedt, Cathleen; Jäger, Dirk; Hohenfellner, Markus; Duensing, Anette; Duensing, Stefan.
Afiliação
  • Li J; Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Pohl L; Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Schüler J; Charles River Laboratories, Am Flughafen 12, D-79108 Freiburg, Germany.
  • Korzeniewski N; Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Reimold P; Department of Urology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany.
  • Kaczorowski A; Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Hou W; Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Zschäbitz S; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
  • Nientiedt C; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg University Hospital, Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany.
  • Hohenfellner M; Department of Urology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany.
  • Duensing A; Precision Oncology of Urological Malignancies, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany.
  • Duensing S; Cancer Therapeutics Program, UPMC Hillman Cancer Center, 5117 Centre Avenue, Pittsburgh, PA 15213, USA.
Biomedicines ; 9(6)2021 May 31.
Article em En | MEDLINE | ID: mdl-34072926
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biomedicines Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha